Amgen (AMGN) Raw Materials (2013 - 2017)

Amgen has reported Raw Materials for 5 years, with the latest figure at $237.0 million in Q2 2017.

• On a quarterly basis, Raw Materials changed N/A year-over-year to $237.0 million in Q2 2017; TTM through Jun 2017 was $237.0 million, a N/A change from a year earlier, with the FY2016 full-year figure at $225.0 million, up 11.94% from the prior year.
• Raw Materials was $237.0 million for Q2 2017 at Amgen, up from $216.0 million in the prior quarter.
• The five-year high for Raw Materials was $237.0 million in Q2 2017, with the low at $198.0 million in Q4 2014.
• Average Raw Materials over 5 years is $214.4 million, with a median of $216.5 million recorded in 2013.
• The sharpest annual moves came in 2014 and 2016: Raw Materials slipped 8.76% in 2014, then rose 11.94% in 2016.
• Over 5 years, Raw Materials stood at $217.0 million in 2013, then declined by 8.76% to $198.0 million in 2014, then climbed by 1.52% to $201.0 million in 2015, then increased by 11.94% to $225.0 million in 2016, then gained by 5.33% to $237.0 million in 2017.
• The last three Raw Materials figures came in at $237.0 million (Q2 2017), $216.0 million (Q1 2017), and $225.0 million (Q4 2016), per Business Quant data.